Skip to main content
. 2019 Apr 24;8(2):55. doi: 10.3390/pathogens8020055

Figure 1.

Figure 1

(A) Schematic showing assembly of D-galactose surface-modified polymeric nanoparticles. (B) Particle size distribution of prepared polymeric nanoparticles. Each data point represents the average particle diameter of an independent formulation. (C) Histogram of particle size distribution for all nanoparticles prepared in this study.